By Scotty T Reid In the annals of history, the oppressed have often been labeled as “human monsters” by the establishment and ruling classes. This…
By Scotty Reid – The World Health Organization predicts that their will be 22 million new cases of cancer per year within the next two decades. The International Agency for Research on Cancer estimated that in 2012 there were 14.1 million new cases of cancer with 8.2 million deaths and those figures will increase due to aging populations and the “spread of cancer” to non-white “developing” countries. A sharp increase in breast cancer was also noted in the report. Experts stated that sixty-percent of cancer cases are in Africa, Asia, Central and South America.
The International Agency for Research on Cancer also reported in 2012 that countries should consider passing regulation to control the consumption of “alcohol and sugary” drinks perhaps prompting the failed attempt by the New York City health board to limit the maximum size of soft drink sold in restaurants. The soft drink ban was overturned in the New York state courts in 2013.
It should also be noted that the one natural plant that has been scientifically proven to have cancer prevention properties, including using its oil to treat leukemia and breast cancer, cannabis has been banned around the world through various treaties associated with the so-called War on Drugs while cancer causing agents like alcohol, soda and tobacco products are legal to consume and widely distributed.
Interestingly, last month Bayer CEO Marijn Dekkers told Bloomberg Businessweek that their new cancer drug Nexavar, isn’t “for Indians,” but “for western patients who can afford it.” referring to a dispute with the Indian government’s ruling that allowed their pharmaceutical companies to produce and market the expensive drug Nexavar at a drastically reduced price.
From Raw Story,
Bayer Pharmaceutical CEO: Cancer drug only ‘for western patients who can afford it’ (via Raw Story )
In an interview with Bloomberg Businessweek, Bayer CEO Marijn Dekkers said that his company’s new cancer drug, Nexavar, isn’t “for Indians,” but “for western patients who can afford it.” The drug, which is particularly effective on late-…